The pharmaceutical industry is witnessing a profound evolution in cancer treatment, driven by the escalating demand for highly targeted therapies.…
Read More
Eli Lilly and Ascidian Therapeutics Forge Strategic Alliance to Pioneer Novel Genetic Medicines for Kidney Diseases
Eli Lilly and Company, a global pharmaceutical leader, has significantly bolstered its commitment to the cutting-edge field of genetic medicines…
Read More
Eli Lilly and Ascidian Therapeutics Forge Strategic Alliance to Revolutionize Kidney Disease Treatment Through Advanced Genetic Medicine
Eli Lilly and Company has announced a significant research collaboration and licensing agreement with Ascidian Therapeutics, a pioneering biotechnology firm…
Read More
SK bioscience and VECOL Forge Strategic Partnership to Bolster Vaccine Self-Sufficiency in Colombia
SK bioscience has signed a significant vaccine technology transfer and manufacturing agreement with Colombia’s state-owned pharmaceutical company, VECOL. This collaboration…
Read More
BD and Wellstar Forge AI-Powered Alliance for End-to-End Medication Management
BD (Becton, Dickinson and Company), a leading global medical technology company, has announced a strategic partnership with Wellstar Health System,…
Read More
Insilico Medicine and Eli Lilly Forge Potentially $2.75 Billion AI-Driven Drug Discovery Alliance, Signaling a New Era of Pharmaceutical Innovation
On March 29, Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, announced a landmark collaboration with…
Read More
OpenBench and Concept Life Sciences Forge Strategic Alliance to Revolutionize Early-Stage Drug Discovery with Fee-for-Success Model
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Global Healthcare Giants Unite: GHO Capital and CBC Group Forge Largest Dedicated Investment Manager with $21 Billion AUM
Two prominent forces in specialized healthcare investment, Global Healthcare Opportunities (GHO) and CBC Group, have announced a groundbreaking merger to…
Read More
Regeneron Pharmaceuticals and Parabilis Medicines Forge Landmark $2.32 Billion Collaboration to Pioneer a New Era of Intracellular Therapies
Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Alliance to Revolutionize Pediatric Diagnostics and Expand National Access
The landscape of clinical diagnostics is poised for a significant transformation following the announcement of a strategic collaboration between Labcorp,…
Read MoreYOU MAY HAVE MISSED
